150 related articles for article (PubMed ID: 33566379)
41. The processing of human rhomboid intramembrane serine protease RHBDL2 is required for its proteolytic activity.
Lei X; Li YM
J Mol Biol; 2009 Dec; 394(5):815-25. PubMed ID: 19850051
[TBL] [Abstract][Full Text] [Related]
42. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells.
Baumann H; Wang Y; Morella KK; Lai CF; Dams H; Hilton DJ; Hawley RG; Mackiewicz A
J Immunol; 1996 Jul; 157(1):284-90. PubMed ID: 8683127
[TBL] [Abstract][Full Text] [Related]
43. A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicing.
Wolf J; Waetzig GH; Reinheimer TM; Scheller J; Rose-John S; Garbers C
Biochem Biophys Res Commun; 2016 Feb; 470(4):870-6. PubMed ID: 26809098
[TBL] [Abstract][Full Text] [Related]
44. Dissecting Interleukin-6 Classic- and Trans-Signaling in Inflammation and Cancer.
Garbers C; Rose-John S
Methods Mol Biol; 2018; 1725():127-140. PubMed ID: 29322414
[TBL] [Abstract][Full Text] [Related]
45. Two differentially expressed interleukin-11 receptor genes in the mouse genome.
Bilinski P; Hall MA; Neuhaus H; Gissel C; Heath JK; Gossler A
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):359-63. PubMed ID: 8973540
[TBL] [Abstract][Full Text] [Related]
46. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6: A Masterplayer in the Cytokine Network.
Uciechowski P; Dempke WCM
Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-11 receptor expression on monocytes is dispensable for their recruitment and pathogen uptake during Leishmania major infection.
Baars I; Lokau J; Sauerland I; Müller AJ; Garbers C
Cytokine; 2021 Dec; 148():155699. PubMed ID: 34530329
[TBL] [Abstract][Full Text] [Related]
49. Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing.
Cheng TL; Wu YT; Lin HY; Hsu FC; Liu SK; Chang BI; Chen WS; Lai CH; Shi GY; Wu HL
J Invest Dermatol; 2011 Dec; 131(12):2486-94. PubMed ID: 21833011
[TBL] [Abstract][Full Text] [Related]
50. Characterization of interleukin-11 receptor and protein tyrosine phosphorylation induced by interleukin-11 in mouse 3T3-L1 cells.
Yin T; Miyazawa K; Yang YC
J Biol Chem; 1992 Apr; 267(12):8347-51. PubMed ID: 1373723
[TBL] [Abstract][Full Text] [Related]
51. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
[TBL] [Abstract][Full Text] [Related]
52. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage.
Prenissl N; Lokau J; Rose-John S; Haybaeck J; Garbers C
Cytokine; 2019 Feb; 114():1-5. PubMed ID: 30557809
[TBL] [Abstract][Full Text] [Related]
54. Identification of three distinct receptor binding sites of murine interleukin-11.
Barton VA; Hudson KR; Heath JK
J Biol Chem; 1999 Feb; 274(9):5755-61. PubMed ID: 10026196
[TBL] [Abstract][Full Text] [Related]
55. Meprin Metalloproteases Generate Biologically Active Soluble Interleukin-6 Receptor to Induce Trans-Signaling.
Arnold P; Boll I; Rothaug M; Schumacher N; Schmidt F; Wichert R; Schneppenheim J; Lokau J; Pickhinke U; Koudelka T; Tholey A; Rabe B; Scheller J; Lucius R; Garbers C; Rose-John S; Becker-Pauly C
Sci Rep; 2017 Mar; 7():44053. PubMed ID: 28276471
[TBL] [Abstract][Full Text] [Related]
56. Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling.
Flynn CM; Garbers Y; Lokau J; Wesch D; Schulte DM; Laudes M; Lieb W; Aparicio-Siegmund S; Garbers C
Sci Rep; 2019 May; 9(1):7306. PubMed ID: 31086276
[TBL] [Abstract][Full Text] [Related]
57. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
[TBL] [Abstract][Full Text] [Related]
58. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
[TBL] [Abstract][Full Text] [Related]
59. Cytokines are a therapeutic target for the prevention of inflammation-induced cancers.
Rose-John S; Schooltink H
Recent Results Cancer Res; 2007; 174():57-66. PubMed ID: 17302185
[TBL] [Abstract][Full Text] [Related]
60. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
